Henkel has developed and introduced to market a new resin for 3D printing that is both resistant to sterilization and biocompatible.

Loctite 3D MED3394 is a significant advancement, according to the company, primarily for its resistance against sterilization methods that commonly challenge other photopolymers in the market. Following up to 25 autoclave cycles, Loctite 3D MED3394 preserves mechanical properties and dimensional stability, alongside high feature accuracy and low solvent absorption. This resin ensures reliable performance in demanding medical applications, Henkel notes. 

In addition to its sterilization resilience, Loctite 3D MED3394 is compliant with ISO 10993 standards for biocompatibility, and is formulated without CMR (carcinogenic, mutagenic, or reproductively hazardous) ingredients. Its dimensional accuracy and stability make it ideal for applications requiring sterilization or chemical resistance, including surgical tools, hospital devices, and clean room environments. Available in both white and sheer black, Loctite 3D MED3394 features impressive heat deflection temperature (HDT) and tensile properties. 

“We are proud of this advancement in the field of medical 3D printing,” said Dr. Daniel Adams, vice president for Loctite 3D Printing at Henkel. “With our new sterilizable material, Loctite 3D MED3394, we are addressing a clear customer need and show our dedication to providing innovative solutions that support healthcare professionals to deliver quality patient care.” 

With its brands, innovations and technologies, Henkel holds leading market positions worldwide in the industrial and consumer businesses. The business unit Adhesive Technologies is the global leader in the market for adhesives, sealants and functional coatings. With Consumer Brands, the company holds leading positions especially in laundry & home care and hair in many markets and categories around the world. In fiscal 2023, Henkel reported sales of more than €21.5 billion and adjusted operating profit of around €2.6 billion. Henkel’s preferred shares are listed in the German stock index DAX. Henkel was founded in 1876 and today employs about 48,000 people worldwide.